Home>Topics>Stocks>Jazz Pharmaceuticals

Jazz Pharmaceuticals

  1. All
  2. Headlines
  1. Defitelio launches in Europe

    Headlines

    Mon, 31 Mar 2014

    Jazz Pharmaceuticals ( JAZZ +3.5% ) and its recent acquisition Gentium launch Defitelio (defibrotide) in Germany and Austria. The rollout will

  2. Aria up premarket on buyout rumors

    Headlines

    Fri, 28 Mar 2014

    Shares of Aria Pharmaceuticals ( ARIA ) are up 7% in premarket trading on rumors that Jazz Pharmaceuticals ( JAZZ ) is mulling a buyout for as much as $20/share versus yesterday's close of $7.60. This would value the acquisition

  3. Jazz price target set at $200

    Headlines

    Fri, 7 Mar 2014

    Barclays reinstates its coverage of Jazz Pharmaceuticals ( JAZZ ) with an Overweight rating and $200 price target. The target represents a 32% premium over today's price. Post your comment!

  4. Wall Street Breakfast: Must-Know News

    Headlines

    Wed, 4 May 2011

    Associates (JKHY): Q3 EPS of $0.38 in-line. Revenue of $240M (+12% Y/Y) misses by $2M . ( PR ) Jazz Pharmaceuticals (JAZZ): Q1 EPS of $0.59 beats by $0.02 . Revenue of $51M (+45% Y/Y) in-line. Shares -0.38

  5. Top 5 Rallying Biotech Stocks Being Snapped Up By Insiders

    Headlines

    Mon, 28 Feb 2011

    Application to the FDA for the injection formula of FUSILEV, used to treat colorectal cancer (Jan. 2011). 4. Jazz Pharmaceuticals , Inc. (JAZZ): Market cap of $920.46M. Moving Averages: The stock is currently 4.28% above its 20

Content Partners